中性粒细胞与淋巴细胞比值能否预测妇科癌症的生存结局?系统综述与Meta分析
该系统综述与Meta分析纳入26项研究共10530例卵巢癌、子宫内膜癌和宫颈癌患者,评估治疗前血中性粒细胞与淋巴细胞比值(NLR)与总生存(OS)及无事件生存(EFS)的关联。NLR高于界值与更差OS(HR 1.65,95%CI 1.44至1.89;P<0.001)和EFS(HR 1.57,95%CI 1.35至1.82;P<0.001)相关,该关联见于所有肿瘤类型。
要点
- 高NLR与妇科癌症患者更差的总生存(HR 1.65,95%CI 1.44至1.89;P<0.001)相关。
- 高NLR与更差的无事件生存(HR 1.57,95%CI 1.35至1.82;P<0.001)相关。
- NLR与OS的关联见于所有肿瘤类型,宫颈癌中局部晚期及接受化疗联合放疗者效应量更大。
核心结论
- 高NLR与妇科恶性肿瘤患者的不良OS和EFS相关。
研究设计与样本
- 系统检索电子数据库,纳入探讨治疗前血NLR与OS及EFS关联的文献。
- 共纳入26项研究、10530例卵巢癌、子宫内膜癌和宫颈癌患者。
- 采用通用逆方差加权随机效应模型进行Meta分析,并按原发肿瘤类型进行亚组分析。
- 采用Meta回归评估临床病理因素对OS和EFS的HR的影响,所有统计检验均为双侧。
主要发现
- 各项研究采用不同界值定义高NLR(范围0.89至5.03)。
- 报告OS的HR的26项研究中,高NLR界值中位数为2.95;报告EFS结局的17项研究中为2.79。
- NLR高于界值与更差OS相关(HR 1.65,95%CI 1.44至1.89;P<0.001)。
- NLR高于界值与更差EFS相关(HR 1.57,95%CI 1.35至1.82;P<0.001)。
- 该关联见于所有肿瘤类型;多数研究纳入早期和晚期疾病患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Presence of a high neutrophil-to-lymphocyte ratio (NLR) has been associated with increased mortality in several malignancies. Here, we quantify the effect of NLR on survival in patients with gynecologic cancers, and examine the effect of clinico-pathologic factors on its prognostic value. METHODS: A systematic search of electronic databases was conducted to identify publications exploring the association of pre-treatment blood NLR with overall survival (OS) and event-free survival (EFS) among patients with ovarian, endometrial and cervical cancers. Data from studies reporting a hazard ratio (HR) and 95% confidence interval (CI) or a p-value (P) were weighted by generic inverse-variance and pooled in a random effects meta-analysis. Subgroup analyses were conducted according to primary tumor type. Meta-regression was performed to evaluate the influence of clinico-pathologic factors on the HR for OS and EFS. All statistical tests were two-sided. RESULTS: Twenty-six studies comprising 10,530 patients were included. Studies used different cut-offs to classify high NLR (range 0.89 to 5.03). The median cut-off for high NLR was 2.95 among twenty-six studies reporting a HR for OS, and 2.79 in seventeen studies reporting EFS outcomes. NLR greater than the cut-off was associated with worse OS (HR 1.65, 95% CI=1.44 to 1.89; P<0.001) and EFS (HR 1.57, 95% CI=1.35 to 1.82; P<0.001). This association was present in all tumor types. Most studies were comprised of patients with both early-stage and advanced disease. In cervical cancer, significant associations between NLR and OS were observed in studies of early- and mixed-stage patients and regression analysis showed a greater magnitude of effect in patients with locally advanced disease and in those who received both chemotherapy and radiation. CONCLUSIONS: High NLR is associated with an adverse OS and EFS in patients with gynecologic malignancies.
引用
- Ethier JL, Desautels DN, Templeton AJ, et al. Is the neutrophil-to-lymphocyte ratio prognostic of survival outcomes in gynecologic cancers? A systematic review and meta-analysis. Gynecol Oncol. 2017. PMID: 28222899. doi:10.1016/j.ygyno.2017.02.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。